I think that is the reasonable number based on the
Post# of 36537
(Total Views: 301)
Posted On: 06/04/2021 6:38:08 AM
I think that is the reasonable number based on the IPO valuation at $500m and GNBT 60% share in that valuation… probably comes in around $2.5. Higher values of course if Excellagen is widely available and even higher if the “Complete Vaccine “ is ready in November… then of course the SP could get stupid …
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼